Duke GI retweeted
🔔As @AmreenDinani said: “ if you can’t keep your liver healthy, you can t keep the rest of your organs healthy🫀”
Read this to learn more from the MASLD expert 👇🏻 #MASLD #liver @Duke_GI_ @dukemedicine
Can improving liver health help protect the heart? Duke GI researcher @AmreenDinani leads a novel clinical trial studying whether Resmetirom can impact both MASH & heart failure, helping redefine metabolic disease as a whole-body condition. #MASH #HFpEF du.ke/p/h5kh
Duke GI retweeted
Congratulations! So well deserved and what a trend setter. Hope to see other programs promote their incredible APPs
Duke GI retweeted
Histologically normal liver was associated with better survival and lower recurrence after hepatic resection for HCC than both cirrhotic and diseased non-cirrhotic liver. These findings challenge the conventional cirrhotic/non-cirrhotic classification.
doi.org/10.1097/LVT.00000000…
Duke GI retweeted

Hepatitis B Foundation@HepBFoundationJul 13
🇺🇸
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Hepatitis B disproportionately affects Asian and African immigrants in the U.S.
During #MinorityMentalHealthMonth, let’s highlight the importance of mental health while managing chronic conditions such as hepatitis B.
👉 hepb.org/blog/minority-healt…
#HepatitisB #MentalHealthMatters
Duke GI retweeted
From our July newsletter: Researchers sought to characterize the timing and predictors of early-onset and late-onset #depression among adults with #GIcancer. Explore the full study in @JournalofGISurg: ow.ly/PBH650ZlbMP
Duke GI retweeted
Save the date: Duke Medical Alumni Weekend is Nov. 13–15, 2026.
Reconnect with classmates, celebrate reunion milestones, attend Breakfast with the Dean, Medicine Grand Rounds, class gatherings, and more.
Registration opens in September.
🔗 Learn more: medschool.duke.edu/about-us/…
Duke GI retweeted
📝 JAMA Review: #AlcoholRelatedLiverDisease is the leading cause of #liver-related #mortality and the most common indication for liver #transplant in Europe and the US, with mortality rates rising over the past two decades.
ALD develops with chronic daily #alcohol consumption (>20 g/d for women, >30 g/d for men) and encompasses reversible #steatosis, #steatohepatitis, #fibrosis, #cirrhosis, and #hepatocellular #carcinoma.
🔗 ja.ma/4eVgvZK
Duke GI retweeted
Thankful to have been a part of this cohort. Great opportunity to connect and make progress in the field of GI.
@ASGEendoscopy @Duke_GI_
Ready to lead the future of GI care?
Only a select group will help shape the future of artificial intelligence in gastroenterology. Will you be one of them?
Now is your chance to join an exclusive group of AI Scholars collaborating with world-renowned mentors on groundbreaking projects driving the next wave of AI-powered care, research and discovery. Applications now open through June 30. hubs.ly/Q04lrcjF0
#AI #GIEndoscopy #Endoscopy #Gastroenterology #AIGI #GIInnovation #ArtificialIntelligence #MedicalInnovation #GITwitter
Duke GI retweeted
Cellular therapies are showing tremendous promise for certain cancers previously thought to be incurable. DCI's Diane Reidy-Lagunes, MD, and Chenyu Lin, MD, discuss how they work and what the future may hold.
duke.is/g/2wps
@DukeHealth | @DukeMedSchool
Duke GI retweeted
Thank you to everyone that joined us at #LICOP night out yesterday! 🫶
If you missed please come join us at room 153B for our annual meeting!
Duke GI retweeted
Standing ovation at ASCO in the middle of the plenary session
Finally some hope for people living with pancreatic cancer
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO

ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Duke GI retweeted
BREAKING NEWS: A major milestone for people living with #HepatitisD.
The FDA has approved #bulevirtide (#Hepcludex), the first approved treatment for chronic #HDV infection.
In this news article, #AASLD member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV.
Read more: bit.ly/4u70DJg.
Duke GI retweeted
Grateful to @APFEDorg for all of their amazing advocacy and support in recognition of World EoE Day...and everyday.
Duke GI retweeted
🎓 We're still celebrating! Congratulations to the 464 students from the Duke University School of Medicine who graduated on Sunday, May 10, 2026.
🔗 Read more about the numbers behind this year's graduates: medschool.duke.edu/news/grad…
Duke GI retweeted
Faculty, staff and residents from the Department of Medicine traded scrubs and laptops for hard hats this spring, partnering with Habitat for Humanity of Durham to help build affordable housing in the community we serve. 🏠💙 medicine.duke.edu/news/under…
Duke GI retweeted
The #DDW2026 Exhibit Hall is officially open! Join us in Hall F (Level 3) from 9:30 a.m. to 4 p.m. or during scientific session breaks each day from 9:30 a.m.–10 a.m., 11:30 a.m.–2 p.m., and 3:30 p.m.–4 p.m.
Duke GI retweeted
Don’t miss out on the AI Scholars Program presentations at @ASGEendoscopy learning center!
@DDWMeeting @Duke_GI_
Duke GI retweeted
How does MASLD link to HFpEF?
Our data point to mitochondrial energy metabolism and kidney-related metabolites as key connections—and potential biomarkers.
Full text: rdcu.be/ffW0W
@SvatiShah @CindyMoylan_MD








































